Effect of Posterolateral Left Ventricular Scar on Mortality and Morbidity following Cardiac Resynchronization Therapy
Objectives: To determine the effect of a posterolateral (PL) left ventricular scar on mortality and morbidity following cardiac resynchronization therapy (CRT). Methods: Sixty‐two patients with heart failure (age 67.3 ± 9.6 yrs [mean ± SD], 45 males, New York Heart Association class [NYHA] class III...
Saved in:
Published in | Pacing and clinical electrophysiology Vol. 30; no. 10; pp. 1201 - 1209 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Malden, USA
Blackwell Publishing Inc
01.10.2007
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Objectives:
To determine the effect of a posterolateral (PL) left ventricular scar on mortality and morbidity following cardiac resynchronization therapy (CRT).
Methods:
Sixty‐two patients with heart failure (age 67.3 ± 9.6 yrs [mean ± SD], 45 males, New York Heart Association class [NYHA] class III or IV, left ventricular ejection fraction [LVEF]= 35%, left bundle branch block, QRS ≥ 120 ms) underwent late gadolinium enhancement cardiovascular magnetic resonance (LGE‐CMR) for scar imaging. Patients were followed up for 741 (75–1602) days (mean [range]).
Results:
The presence of a PL scar emerged as an independent predictor of the composite endpoint of cardiovascular death or hospitalization for worsening heart failure (HR: 3.06 [1.63, 7.7, P < 0.0001]) as well as the endpoint of cardiovascular death (HR: 2.63 [1.39, 6.65], P = 0.0016). A transmural PL scar was the strongest predictor of these endpoints (both P < 0.0001). The symptomatic responder rate (improvement by ≥1 NYHA classes or ≥25% in 6‐min walking distance) was 83% in the group with non‐PL scars, but only 47% in the group with transmural PL scars (P < 0.0001). Pacing over the scar was associated with a higher mortality and morbidity than pacing outside the scar (all P < 0.05).
Conclusions:
A PL scar is associated with a worse clinical outcome following CRT, particularly if it is transmural. Pacing scarred left ventricular myocardium carries a greater risk of mortality and morbidity than pacing nonscarred myocardium. |
---|---|
Bibliography: | ark:/67375/WNG-RK6VPPHN-R istex:04EB26C8B3372439CF0F7E65DC652BF7FC7B7FAF ArticleID:PACE841 Conflict of interest: S.C. and S.M held research fellowships sponsored by Medtronic Inc. B.S. is employed by Medtronic Inc. R.E.A.S. and F.L. have received sponsorship from Medtronic Inc. and from St. Jude Medical. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0147-8389 1540-8159 |
DOI: | 10.1111/j.1540-8159.2007.00841.x |